NCT01510899View on ClinicalTrials.gov

A Study on the Effect of Renal Impairment on the Pharmacokinetics of RO4917838

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

October 31, 2011

Primary Completion Date

March 31, 2012

Study Completion Date

March 31, 2012

Conditions
Healthy Volunteer
Interventions
DRUG

RO4917838

Single dose of RO4917838

DRUG

RO4917838

Single dose of RO4917838

Trial Locations (3)

35042

Rennes

117192

Moscow

117292

Moscow

All Listed Sponsors
lead

Hoffmann-La Roche

INDUSTRY

NCT01510899 - A Study on the Effect of Renal Impairment on the Pharmacokinetics of RO4917838 | Biotech Hunter | Biotech Hunter